MedTrace Logo

Effects of Early Vestibular Rehabilitation in Patients With Dizziness and Balance Disorders After Sport Concussion

NCT02945605 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2018-05-30

No results posted yet for this study

Summary

This study examines the effect of early vestibular rehabilitation on reducing physical post-concussion symptoms (e.g. dizziness, balance problems) and improving the timeline to achieve medical clearance to return to activities such as sports and work activities. Half of the participants will receive early vestibular rehabilitation added to standard of care, while the other half will receive standard of care only.

Conditions

  • Brain Concussion

Interventions

OTHER

Early Vestibular Rehabilitation

Two visits/week for a maximum of 5 weeks will be provided with the approximate duration for each visit estimated at 50-60 minutes. Consistent with a previously validated framework for exercise prescription in patients with concussion, the exercises provided by the treating therapist can be classified into five main exercise categories: 1. Eye-Head coordination, gaze stability and convergence exercises 2. Sitting balance 3. Standing static balance (i.e. feet-in-place) 4. Dynamic balance (feet moving, but not walking) 5. Ambulation (gait exercises) 6. Other exercises: Sport specific exercises, Canalith repositioning maneuvers are recorded as others

OTHER

Standard of Care

Standard care as directed by a physician.

Sponsors & Collaborators

Principal Investigators

  • Bara Alsalaheen, PT, PhD · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-09
Primary Completion
2017-03-21
Completion
2017-03-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02945605 on ClinicalTrials.gov